Authors: Dovey, HF John, V Anderson, JP Chen, LZ Andrieu, PD Fang, LY Freedman, SB Folmer, B Goldbach, E Holsztynska, EJ Hu, KL Johnson-Wood, KL Kennedy, SL Kholedenko, D Knops, JE Latimer, LH Lee, M Liao, Z Lieberburg, IM Motter, RN Mutter, LC Nietz, J Quinn, KP Sacchi, KL Seubert, PA Shopp, GM Thorsett, ED Tung, JS Wu, J Yang, S Yin, CT Schenk, DB May, PC Altstiel, LD Bender, MH Boggs, LN Britton, TC Clemens, JC Czilli, DL Dieckman-McGinty, DK Droste, JJ Fuson, KS Gitter, BD Hyslop, PA Johnstone, EM Li, WY Little, SP Mabry, TE Miller, FD Ni, B Nissen, JS Porter, WJ Potts, BD Reel, JK Stephenson, D Su, Y Shipley, LA Whitesitt, CA Yin, T Audia, JE

Citation: Hf. Dovey et al., Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain, J NEUROCHEM, 76(1), 2001, pp. 173-181

Authors: Schenk, DB Seubert, P Lieberburg, I Wallace, J

Citation: Db. Schenk et al., beta-peptide immunization - A possible new treatment for Alzheimer disease, ARCH NEUROL, 57(7), 2000, pp. 934-936